Cibus Therapeutics, a clinical-stage biotech company based in Palo Alto, California, has a vision: to transform the treatment of gastrointestinal diseases through pioneering small-molecule therapies. By integrating advanced molecular insights with a robust clinical pipeline, we aim to disrupt disease progression and offer meaningful therapy to patients. Our collaborative approach, rooted in Stanford Medicine’s world class patient care, Silicon Valley’s entrepreneurial spirit, and robust investment at the heart of the innovation ecosystem positions us to  redefine care standards and bring hope to patients worldwide.